DENV4 NS1 Antibody Patent US12606611B2 Granted to US Dept Health

Tue, 21 Apr 2026 13:30:11 +0000
Intellectual Property

The USPTO granted Patent No. US12606611B2 to the United States of America, as represented by the Secretary of the Department of Health & Human Services, covering antibodies that specifically bind to Dengue virus serotype 4 (DENV4) non-structural protein 1 (NS1). The patent includes 16 claims and names Elizabeth Anne Hunsperger and Tesfaye Gelanew Taye as inventors.